U.S. Court of Appeals for the First Circuit, 2023

In Re: Zofran (Ondansetron) Products Liability Lit v.

In Re: Zofran (Ondansetron) Products Liability Lit v.
U.S. Court of Appeals for the First Circuit · Decided January 12, 2023

In Re: Zofran (Ondansetron) Products Liability Lit v.

Opinion

United States Court of Appeals For the First Circuit

No. 21-1517 IN RE: ZOFRAN (ONDANSETRON) PRODUCTS LIABILITY LITIGATION

HEATHER PERHAM, et al., Plaintiffs, Appellants, v. GLAXOSMITHKLINE LLC, Defendant, Appellee, SUN PHARMACEUTICAL INDUSTRIES LTD.; SANDOZ, INC.; PROVIDENCE HEALTH SYSTEM; NOVARTIS PHARMACEUTICALS CORP.; MCKESSON CORPORATION; DOES 1 through 100, inclusive, TEVA PHARMACEUTICAL USA; GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC., Defendants.

ERRATA SHEET The opinion of this Court issued on January 9, 2022, is amended as follows: On page 3, line 24, "U.S.C.A." is replaced with "U.S.C."

Case-law data current through December 31, 2025. Source: CourtListener bulk data.